Revolution Medicines RVMD
Jeff Cislini (Officer) plans to sell 1,700 RVMD shares, about $68,578
- Form
- 144
- Filed
- Importance
- Routine
- Accession
- 0001230439-24-000026
- Document
- Form 144
- Approximate sale date: Jun 17, 2024
- Broker: ETrade Financial Corporation
- Shares acquired by: Restricted stock unit grant
- 10b5-1 plan adopted: May 31, 2023
Written from the Form 144 on EDGAR. AI can make mistakes. Check the filing.
Similar companies
Companies of similar size in SIC 2836 and related industry codes: the same peer list as the financial tables.
- Biomarin Pharmaceutical BMRN public float $6.7B, Jun 30, 2025
- Jazz Pharmaceuticals JAZZ public float $6.3B, Jun 30, 2025
- Corcept Therapeutics CORT public float $6.1B, Jun 30, 2025
- Repligen RGEN public float $6.0B, Jun 30, 2025
- Madrigal Pharmaceuticals MDGL public float $5.6B, Jun 30, 2025
